Selected research
Market Outlook & Growth Opportunities
Global Plant Extract Drug Market Outlook and Growth Opportunities 2026
Market perspective
The global Plant Extract Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Plant Extract Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Plant Extract Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plant Extract Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Plant Extract Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Plant Extract Drug market include Guangzhou Baiyunshan Pharmaceutical, Buchang Pharmaceuticals, Yunnan Baiyao, Weleda, Tsumura, Tong Ren Tang, Tasly Holding Group, Taiji and Schwabe, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Plant Extract Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Plant Extract Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plant Extract Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Plant Extract Drug market.
Plant Extract Drug Segment by Company
Guangzhou Baiyunshan Pharmaceutical
Buchang Pharmaceuticals
Yunnan Baiyao
Weleda
Tsumura
Tong Ren Tang
Tasly Holding Group
Taiji
Schwabe
Kwangdong
Jumpcan Pharmaceutical
Huarun 999
GW Pharmaceuticals
China TCM
Bionorica Se
Plant Extract Drug Segment by Type
Prescription Drug
OTC
Plant Extract Drug Segment by Application
Tumor
Cardiovascular
Respiratory System
Other
Plant Extract Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Plant Extract Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Plant Extract Drug key companies, revenue, market share, and recent developments.
3. To split the Plant Extract Drug breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Plant Extract Drug market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Plant Extract Drug significant trends, drivers, influence factors in global and regions.
6. To analyze Plant Extract Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant Extract Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plant Extract Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant Extract Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plant Extract Drug industry.
Chapter 3: Detailed analysis of Plant Extract Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Plant Extract Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Plant Extract Drug in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Plant Extract Drug Industry Trends
Table 2. Plant Extract Drug Industry Drivers
Table 3. Plant Extract Drug Industry Opportunities and Challenges
Table 4. Plant Extract Drug Industry Restraints
Table 5. Global Plant Extract Drug Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Plant Extract Drug Revenue Share by Company (2021-2026)
Table 7. Global Plant Extract Drug Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Plant Extract Drug Key Company Manufacturing Base & Headquarters
Table 9. Global Plant Extract Drug Company, Product Type & Application
Table 10. Global Plant Extract Drug Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Plant Extract Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Prescription Drug
Table 15. Significant Companies of OTC
Table 16. Global Plant Extract Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 17. Global Plant Extract Drug Sales Value by Type (2021-2026) & (US$ Million)
Table 18. Global Plant Extract Drug Sales Value by Type (2027-2032) & (US$ Million)
Table 19. Global Plant Extract Drug Sales Value Share by Type (2021-2026)
Table 20. Global Plant Extract Drug Sales Value Share by Type (2027-2032)
Table 21. Significant Companies of Tumor
Table 22. Significant Companies of Cardiovascular
Table 23. Significant Companies of Respiratory System
Table 24. Significant Companies of Other
Table 25. Global Plant Extract Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 26. Global Plant Extract Drug Sales Value by Application (2021-2026) & (US$ Million)
Table 27. Global Plant Extract Drug Sales Value by Application (2027-2032) & (US$ Million)
Table 28. Global Plant Extract Drug Sales Value Share by Application (2021-2026)
Table 29. Global Plant Extract Drug Sales Value Share by Application (2027-2032)
Table 30. Global Plant Extract Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. Global Plant Extract Drug Sales Value by Region (2021-2026) & (US$ Million)
Table 32. Global Plant Extract Drug Sales Value Share by Region (2021-2026)
Table 33. Global Plant Extract Drug Sales Value by Region (2027-2032) & (US$ Million)
Table 34. Global Plant Extract Drug Sales Value Share by Region (2027-2032)
Table 35. Global Plant Extract Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 36. Global Plant Extract Drug Sales Value by Country (2021-2026) & (US$ Million)
Table 37. Global Plant Extract Drug Sales Value Market Share by Country (2021-2026)
Table 38. Global Plant Extract Drug Sales Value by Country (2027-2032) & (US$ Million)
Table 39. Global Plant Extract Drug Sales Value Market Share by Country (2027-2032)
Table 40. Guangzhou Baiyunshan Pharmaceutical Company Information
Table 41. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 42. Guangzhou Baiyunshan Pharmaceutical Plant Extract Drug Revenue (US$ Million) and Gross Margin (2021-2026)
Table 43. Guangzhou Baiyunshan Pharmaceutical Plant Extract Drug Product Portfolio
Table 44. Guangzhou Baiyunshan Pharmaceutical Recent Development
Table 45. Buchang Pharmaceuticals Company Information
Table 46. Buchang Pharmaceuticals Business Overview
Table 47. Buchang Pharmaceuticals Plant Extract Drug Revenue (US$ Million) and Gross Margin (2021-2026)
Table 48. Buchang Pharmaceuticals Plant Extract Drug Product Portfolio
Table 49. Buchang Pharmaceuticals Recent Development
Table 50. Yunnan Baiyao Company Information
Table 51. Yunnan Baiyao Business Overview
Table 52. Yunnan Baiyao Plant Extract Drug Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. Yunnan Baiyao Plant Extract Drug Product Portfolio
Table 54. Yunnan Baiyao Recent Development
Table 55. Weleda Company Information
Table 56. Weleda Business Overview
Table 57. Weleda Plant Extract Drug Revenue (US$ Million) and Gross Margin (2021-2026)
Table 58. Weleda Plant Extract Drug Product Portfolio
Table 59. Weleda Recent Development
Table 60. Tsumura Company Information
Table 61. Tsumura Business Overview
Table 62. Tsumura Plant Extract Drug Revenue (US$ Million) and Gross Margin (2021-2026)
Table 63. Tsumura Plant Extract Drug Product Portfolio
Table 64. Tsumura Recent Development
Table 65. Tong Ren Tang Company Information
Table 66. Tong Ren Tang Business Overview
Table 67. Tong Ren Tang Plant Extract Drug Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Tong Ren Tang Plant Extract Drug Product Portfolio
Table 69. Tong Ren Tang Recent Development
Table 70. Tasly Holding Group Company Information
Table 71. Tasly Holding Group Business Overview
Table 72. Tasly Holding Group Plant Extract Drug Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. Tasly Holding Group Plant Extract Drug Product Portfolio
Table 74. Tasly Holding Group Recent Development
Table 75. Taiji Company Information
Table 76. Taiji Business Overview
Table 77. Taiji Plant Extract Drug Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. Taiji Plant Extract Drug Product Portfolio
Table 79. Taiji Recent Development
Table 80. Schwabe Company Information
Table 81. Schwabe Business Overview
Table 82. Schwabe Plant Extract Drug Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Schwabe Plant Extract Drug Product Portfolio
Table 84. Schwabe Recent Development
Table 85. Kwangdong Company Information
Table 86. Kwangdong Business Overview
Table 87. Kwangdong Plant Extract Drug Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Kwangdong Plant Extract Drug Product Portfolio
Table 89. Kwangdong Recent Development
Table 90. Jumpcan Pharmaceutical Company Information
Table 91. Jumpcan Pharmaceutical Business Overview
Table 92. Jumpcan Pharmaceutical Plant Extract Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Jumpcan Pharmaceutical Plant Extract Drug Product Portfolio
Table 94. Jumpcan Pharmaceutical Recent Development
Table 95. Huarun 999 Company Information
Table 96. Huarun 999 Business Overview
Table 97. Huarun 999 Plant Extract Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Huarun 999 Plant Extract Drug Product Portfolio
Table 99. Huarun 999 Recent Development
Table 100. GW Pharmaceuticals Company Information
Table 101. GW Pharmaceuticals Business Overview
Table 102. GW Pharmaceuticals Plant Extract Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. GW Pharmaceuticals Plant Extract Drug Product Portfolio
Table 104. GW Pharmaceuticals Recent Development
Table 105. China TCM Company Information
Table 106. China TCM Business Overview
Table 107. China TCM Plant Extract Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. China TCM Plant Extract Drug Product Portfolio
Table 109. China TCM Recent Development
Table 110. Bionorica Se Company Information
Table 111. Bionorica Se Business Overview
Table 112. Bionorica Se Plant Extract Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Bionorica Se Plant Extract Drug Product Portfolio
Table 114. Bionorica Se Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Authors List of This Report
Table 117. Secondary Sources
Table 118. Primary Sources
List of Figures
Figure 1. Plant Extract Drug Product Image
Figure 2. Global Plant Extract Drug Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Plant Extract Drug Market Size (2021-2032) & (US$ Million)
Figure 4. Global Plant Extract Drug Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Prescription Drug Image
Figure 8. OTC Image
Figure 9. Global Plant Extract Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Plant Extract Drug Sales Value Share 2021 VS 2025 VS 2032
Figure 11. Global Plant Extract Drug Sales Value Share by Type (2021-2032)
Figure 12. Tumor Image
Figure 13. Cardiovascular Image
Figure 14. Respiratory System Image
Figure 15. Other Image
Figure 16. Global Plant Extract Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 17. Global Plant Extract Drug Sales Value Share 2021 VS 2025 VS 2032
Figure 18. Global Plant Extract Drug Sales Value Share by Application (2021-2032)
Figure 19. Global Plant Extract Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 20. Global Plant Extract Drug Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 21. North America Plant Extract Drug Sales Value (2021-2032) & (US$ Million)
Figure 22. North America Plant Extract Drug Sales Value Share by Country (%), 2025 VS 2032
Figure 23. Europe Plant Extract Drug Sales Value (2021-2032) & (US$ Million)
Figure 24. Europe Plant Extract Drug Sales Value Share by Country (%), 2025 VS 2032
Figure 25. Asia-Pacific Plant Extract Drug Sales Value (2021-2032) & (US$ Million)
Figure 26. Asia-Pacific Plant Extract Drug Sales Value Share by Country (%), 2025 VS 2032
Figure 27. South America Plant Extract Drug Sales Value (2021-2032) & (US$ Million)
Figure 28. South America Plant Extract Drug Sales Value Share by Country (%), 2025 VS 2032
Figure 29. Middle East & Africa Plant Extract Drug Sales Value (2021-2032) & (US$ Million)
Figure 30. Middle East & Africa Plant Extract Drug Sales Value Share by Country (%), 2025 VS 2032
Figure 31. USA Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 32. USA Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 33. USA Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 34. Canada Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 35. Canada Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 36. Canada Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 37. Mexico Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 38. Mexico Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 39. Mexico Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 40. Germany Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. Germany Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. Germany Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. France Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. France Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. France Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. U.K. Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. U.K. Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. U.K. Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. Italy Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. Italy Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. Italy Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. Spain Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. Spain Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. Spain Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. Russia Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. Russia Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. Russia Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Netherlands Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Netherlands Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Netherlands Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Nordic Countries Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Nordic Countries Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Nordic Countries Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. China Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. China Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. China Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. Japan Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. Japan Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. Japan Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. South Korea Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. South Korea Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. South Korea Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. India Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. India Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. India Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. Australia Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. Australia Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. Australia Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. Southeast Asia Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. Southeast Asia Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. Southeast Asia Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. Brazil Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. Brazil Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. Brazil Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Argentina Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Argentina Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Argentina Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Chile Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Chile Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Chile Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Colombia Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Colombia Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Colombia Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Peru Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Peru Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Peru Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Saudi Arabia Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Saudi Arabia Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Saudi Arabia Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Israel Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Israel Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Israel Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. UAE Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. UAE Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. UAE Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. Turkey Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. Turkey Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. Turkey Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. Iran Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. Iran Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. Iran Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. Egypt Plant Extract Drug Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. Egypt Plant Extract Drug Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. Egypt Plant Extract Drug Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Years Considered
Figure 116. Research Process
Figure 117. Key Executives Interviewed
Scope & coverage.
Types
- Prescription Drug
- OTC
Applications
- Tumor
- Cardiovascular
- Respiratory System
- Other
Companies covered
- Guangzhou Baiyunshan Pharmaceutical
- Buchang Pharmaceuticals
- Yunnan Baiyao
- Weleda
- Tsumura
- Tong Ren Tang
- Tasly Holding Group
- Taiji
- Schwabe
- Kwangdong
- Jumpcan Pharmaceutical
- Huarun 999
- GW Pharmaceuticals
- China TCM
- Bionorica Se
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Plant Extract Drug Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Plant Extract Drug Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Plant Extract Drug Market Dynamics
- 2.1 Plant Extract Drug Industry Trends
- 2.2 Plant Extract Drug Industry Drivers
- 2.3 Plant Extract Drug Industry Opportunities and Challenges
- 2.4 Plant Extract Drug Industry Restraints
3 Plant Extract Drug Market by Company
- 3.1 Global Plant Extract Drug Company Revenue Ranking in 2025
- 3.2 Global Plant Extract Drug Revenue by Company (2021-2026)
- 3.3 Global Plant Extract Drug Company Ranking (2024-2026)
- 3.4 Global Plant Extract Drug Company Manufacturing Base and Headquarters
- 3.5 Global Plant Extract Drug Company Product Type and Application
- 3.6 Global Plant Extract Drug Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Plant Extract Drug Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Plant Extract Drug Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Plant Extract Drug Market by Type
- 4.1 Plant Extract Drug Type Introduction
- 4.1.1 Prescription Drug
- 4.1.2 OTC
- 4.2 Global Plant Extract Drug Sales Value by Type
- 4.2.1 Global Plant Extract Drug Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Plant Extract Drug Sales Value by Type (2021-2032)
- 4.2.3 Global Plant Extract Drug Sales Value Share by Type (2021-2032)
5 Plant Extract Drug Market by Application
- 5.1 Plant Extract Drug Application Introduction
- 5.1.1 Tumor
- 5.1.2 Cardiovascular
- 5.1.3 Respiratory System
- 5.1.4 Other
- 5.2 Global Plant Extract Drug Sales Value by Application
- 5.2.1 Global Plant Extract Drug Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Plant Extract Drug Sales Value by Application (2021-2032)
- 5.2.3 Global Plant Extract Drug Sales Value Share by Application (2021-2032)
6 Plant Extract Drug Regional Value Analysis
- 6.1 Global Plant Extract Drug Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Plant Extract Drug Sales Value by Region (2021-2032)
- 6.2.1 Global Plant Extract Drug Sales Value by Region: 2021-2026
- 6.2.2 Global Plant Extract Drug Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Plant Extract Drug Sales Value (2021-2032)
- 6.3.2 North America Plant Extract Drug Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Plant Extract Drug Sales Value (2021-2032)
- 6.4.2 Europe Plant Extract Drug Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Plant Extract Drug Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Plant Extract Drug Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Plant Extract Drug Sales Value (2021-2032)
- 6.6.2 South America Plant Extract Drug Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Plant Extract Drug Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Plant Extract Drug Sales Value Share by Country, 2025 VS 2032
7 Plant Extract Drug Country-level Value Analysis
- 7.1 Global Plant Extract Drug Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Plant Extract Drug Sales Value by Country (2021-2032)
- 7.2.1 Global Plant Extract Drug Sales Value by Country (2021-2026)
- 7.2.2 Global Plant Extract Drug Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.7.2 France Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.14.2 China Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.17.2 India Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Plant Extract Drug Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Plant Extract Drug Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Plant Extract Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Guangzhou Baiyunshan Pharmaceutical
- 8.1.1 Guangzhou Baiyunshan Pharmaceutical Company Information
- 8.1.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
- 8.1.3 Guangzhou Baiyunshan Pharmaceutical Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.1.4 Guangzhou Baiyunshan Pharmaceutical Plant Extract Drug Product Portfolio
- 8.1.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
- 8.2 Buchang Pharmaceuticals
- 8.2.1 Buchang Pharmaceuticals Company Information
- 8.2.2 Buchang Pharmaceuticals Business Overview
- 8.2.3 Buchang Pharmaceuticals Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.2.4 Buchang Pharmaceuticals Plant Extract Drug Product Portfolio
- 8.2.5 Buchang Pharmaceuticals Recent Developments
- 8.3 Yunnan Baiyao
- 8.3.1 Yunnan Baiyao Company Information
- 8.3.2 Yunnan Baiyao Business Overview
- 8.3.3 Yunnan Baiyao Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.3.4 Yunnan Baiyao Plant Extract Drug Product Portfolio
- 8.3.5 Yunnan Baiyao Recent Developments
- 8.4 Weleda
- 8.4.1 Weleda Company Information
- 8.4.2 Weleda Business Overview
- 8.4.3 Weleda Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.4.4 Weleda Plant Extract Drug Product Portfolio
- 8.4.5 Weleda Recent Developments
- 8.5 Tsumura
- 8.5.1 Tsumura Company Information
- 8.5.2 Tsumura Business Overview
- 8.5.3 Tsumura Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.5.4 Tsumura Plant Extract Drug Product Portfolio
- 8.5.5 Tsumura Recent Developments
- 8.6 Tong Ren Tang
- 8.6.1 Tong Ren Tang Company Information
- 8.6.2 Tong Ren Tang Business Overview
- 8.6.3 Tong Ren Tang Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.6.4 Tong Ren Tang Plant Extract Drug Product Portfolio
- 8.6.5 Tong Ren Tang Recent Developments
- 8.7 Tasly Holding Group
- 8.7.1 Tasly Holding Group Company Information
- 8.7.2 Tasly Holding Group Business Overview
- 8.7.3 Tasly Holding Group Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.7.4 Tasly Holding Group Plant Extract Drug Product Portfolio
- 8.7.5 Tasly Holding Group Recent Developments
- 8.8 Taiji
- 8.8.1 Taiji Company Information
- 8.8.2 Taiji Business Overview
- 8.8.3 Taiji Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.8.4 Taiji Plant Extract Drug Product Portfolio
- 8.8.5 Taiji Recent Developments
- 8.9 Schwabe
- 8.9.1 Schwabe Company Information
- 8.9.2 Schwabe Business Overview
- 8.9.3 Schwabe Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.9.4 Schwabe Plant Extract Drug Product Portfolio
- 8.9.5 Schwabe Recent Developments
- 8.10 Kwangdong
- 8.10.1 Kwangdong Company Information
- 8.10.2 Kwangdong Business Overview
- 8.10.3 Kwangdong Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.10.4 Kwangdong Plant Extract Drug Product Portfolio
- 8.10.5 Kwangdong Recent Developments
- 8.11 Jumpcan Pharmaceutical
- 8.11.1 Jumpcan Pharmaceutical Company Information
- 8.11.2 Jumpcan Pharmaceutical Business Overview
- 8.11.3 Jumpcan Pharmaceutical Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.11.4 Jumpcan Pharmaceutical Plant Extract Drug Product Portfolio
- 8.11.5 Jumpcan Pharmaceutical Recent Developments
- 8.12 Huarun 999
- 8.12.1 Huarun 999 Company Information
- 8.12.2 Huarun 999 Business Overview
- 8.12.3 Huarun 999 Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.12.4 Huarun 999 Plant Extract Drug Product Portfolio
- 8.12.5 Huarun 999 Recent Developments
- 8.13 GW Pharmaceuticals
- 8.13.1 GW Pharmaceuticals Company Information
- 8.13.2 GW Pharmaceuticals Business Overview
- 8.13.3 GW Pharmaceuticals Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.13.4 GW Pharmaceuticals Plant Extract Drug Product Portfolio
- 8.13.5 GW Pharmaceuticals Recent Developments
- 8.14 China TCM
- 8.14.1 China TCM Company Information
- 8.14.2 China TCM Business Overview
- 8.14.3 China TCM Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.14.4 China TCM Plant Extract Drug Product Portfolio
- 8.14.5 China TCM Recent Developments
- 8.15 Bionorica Se
- 8.15.1 Bionorica Se Company Information
- 8.15.2 Bionorica Se Business Overview
- 8.15.3 Bionorica Se Plant Extract Drug Revenue and Gross Margin (2021-2026)
- 8.15.4 Bionorica Se Plant Extract Drug Product Portfolio
- 8.15.5 Bionorica Se Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst